In vitro and in vivo effects of ingavirin® on the ultrastructure and infectivity of influenza virus

Voprosy Virusologii

Volumn 56, Issue 5, 2011, Pages 21-25

  Zarubayev, V V ^a   Belyaevskaya, S V ^a   Sirotkin, A K ^a   Anfimov, P M ^a   Nebolsin, V E ^b   Kiselev, O I ^a   Reikhart, D V ^c  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b OAO Valenta Pharm   (Russian Federation)

^c I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Antivirals; Electron microscopy; Influenza; Ingavirin; Morphology

Indexed keywords

EID: 82455186323     PISSN: 05074088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Bourmakina S. V, Garcia-Sastre A. Reverse genetics studies on the filamentous morphology of influenza A virus // J. Gen. Virol. - 2003. - Vol. 84, N 3. - P. 517-527.
2. Bruce E. A., Digard P., Stuart A. D. The Rabill pathway is required for influenza A virus budding and filament formation // J. Virol. - 2010. - Vol. 84, N 12. - P. 5848-5859.
3. Burleigh L. M., Calder L. J. Skehel J. J., Steinhauer D. A. Influenza A viruses with mutations in the m 1 helix six domain display a wide variety of morphological phenotypes // J. Virol. - 2005. - Vol. 79, N 2. - P. 1262-1270.
4. Calder L. J., Wasilewski S., Berriman J. A., Rosenthal P. B. Structural organization of a filamentous influenza A virus // Proc. Natl. Acad. Sci. USA. - 2010. - Vol. 107, N 23. - P. 10685-10690.
5. Chazal N., Gerlier D. Virus entry, assembly, budding, and membrane rafts // Microbiol. Mol. Biol. Rev. - 2003. -Vol. 67, N 2. - P. 226-237.
6. Colman P. M. A novel approach to antiviral therapy for influenza // J. Antimicrob. Chemother. - 1999. - Vol. 44 (suppl. B). - P. 17-22.
7. Leser G. P., Lamb R. A. Influenza virus assembly and budding in raft-derived microdomains: a quantitative analysis of the surface distribution of HA, NA and M2 proteins // Virology. - 2005. - Vol. 342, N 2. - P. 215-227.
8. Mancuso C. E., Gabay M. P., Steinke L. M., Vanosdol S. J. Peramivir: an intravenous neuraminidase inhibitor for the treatment of 2009 H1N1 influenza // Ann. Pharmacother. - 2010. - Vol. 44, N 7-8. - P. 1240-1249.
9. Noda T., Sagara H., Yen A. et al. Architecture of ribonucleoprotein complexes in influenza A virus particles // Nature. - 2006. - Vol. 439, N 7075. - P. 490-492.
10. Roberts P. C., Lamb R. A., Compans R. W. The Mi and M2 proteins of influenza A virus are important determinants in filamentous particle formation // Virology. - 1998. - Vol. 240, N 1. - P. 127-137.
11. Rossman J. S., Jing X., Leser G. P. et al. Influenza virus m2 ion channel protein is necessary for filamentous virion formation // J. Virol. - 2010. - Vol. 84, N 10. - P. 5078-5088.
12. Rossman J. S., Lamb R. A. Influenza virus assembly and budding // Virology. - 2011. - Vol. 411, N 2. - P. 229-236.
13. Scholtissek C., Quack G., Klenk H. D. et al. How to overcome resistance of influenza A viruses against adamantine derivatives // Antiviral Res. - 1998. - Vol. 37. - P. 83-95.
14. Yamada K., Ogawa H., Hara A. et al. Mechanism of the antiviral effect of hydroxytyrosol on influenza virus appears to involve morphological change of the virus // Antiviral Res. - 2009. -Vol. 83, N 1. - P. 35-44.